Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.

Saved in:
Bibliographic Details
Title: Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.
Authors: Valle LF; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; Department of Radiation Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA., Nickols NG; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; Department of Radiation Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Hausler R; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Alba PR; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA., Anglin-Foote T; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA., Perez C; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA., Yamoah K; Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.; James A. Haley Veterans' Hospital, Tampa, FL, USA., Rose BS; Department of Radiation Oncology, University of California, San Diego, CA, USA.; Veterans Affairs San Diego Healthcare System, San Diego, CA., Kelley MJ; Duke University Medical Center, Durham, NC, USA.; Department of Veteran Affairs Medical Center, Durham, NC, USA., DuVall SL; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA., Garraway IP; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Lynch JA; Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.; Department of Nursing and Health Sciences, University of Massachusetts, Boston, MA, USA.
Source: The oncologist [Oncologist] 2023 Jun 02; Vol. 28 (6), pp. e473-e477.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyad042